Interventional Oncology Devices | Market Insights | US | 2025
The US market for interventional oncology devices will be driven by uptake of advanced and higher-priced technologies—such as radioembolization—favorable clinical data, expanding populations that are treatable with ablation, and updates to clinical guidelines.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in the US from 2019 through 2033.